Related Experiment Videos

Necrotizing soft tissue infections

Adam M Shiroff1, Georg N Herlitz, Vicente H Gracias

  • 1Division of Acute Care Surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

Insights

Necrotising soft tissue infection (NSTI) requires a high index of suspicion for early diagnosis and management. Prompt surgical exploration and aggressive debridement are crucial for successful outcomes in patients with this aggressive infection.

Area of Science:

  • Infectious Diseases
  • Surgical Pathology
  • Critical Care Medicine

Background:

  • Necrotising soft tissue infection (NSTI) presents diagnostic and management challenges.
  • Understanding NSTI subtypes (Type I and Type II) is crucial for patient stratification.
  • Pathophysiology involves microbial factors leading to rapid tissue destruction and sepsis.

Purpose of the Study:

  • To highlight the diagnostic challenges and management strategies for NSTI.
  • To differentiate between NSTI types based on patient demographics and microbial etiology.
  • To emphasize the importance of early surgical intervention and multidisciplinary care.

Main Methods:

  • Clinical presentation analysis of NSTI types.
  • Review of pathophysiology including superantigen activity and pus viscosity.
  • Evaluation of diagnostic tools like physical examination and the Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) score.
  • Emphasis on surgical exploration and debridement.

Main Results:

  • Type I NSTI: older, less healthy patients, trunk, polymicrobial. Type II NSTI: younger, healthier patients, extremities, trauma history, monomicrobial.
  • Tenderness beyond redness is a key finding; absence of crepitus is not reassuring.
  • LRINEC score shows potential for excluding suspected NSTI cases.
  • Early surgical exploration and debridement are vital.

Conclusions:

  • Early recognition and surgical exploration are paramount for managing NSTI.
  • Aggressive serial debridement and multidisciplinary critical care are essential for improving patient outcomes.
  • While LRINEC shows promise, clinical suspicion should guide management decisions.

Related Concept Videos

Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...